A Study to Evaluate the Effects of LCI699 on Safety and Efficacy in Subjects With Resistant Hypertension Receiving Combination Therapy With Three or More Antihypertensive Drugs, Including a Diuretic
This study has been completed.
Sponsor:
Novartis
Collaborators:
Great Lakes Drug Development, Inc.
Integrium
Information provided by (Responsible Party):
Novartis
ClinicalTrials.gov Identifier:
NCT00817635
First received: January 5, 2009
Last updated: November 30, 2012
Last verified: November 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | October 2009 |
| Primary Completion Date: | October 2009 (Final data collection date for primary outcome measure) |
| Certification or Request for Extension to Delay Results Received: | November 30, 2012 |